These scenarios would represent a substantial departure from current knowledge and would require a fundamentally new understanding of Epo biology in tumors, and thus be a substantial departure from the assumptions underlying the hypothesis that Epo is a “tumor growth factor”, and that EpoR is widely expressed and functional on epithelial tumors. The gene discussed is EPO; the disease is neoplasm.